Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Depression 2Neoplasms 1Neoplasm Metastasis 1Hospice 1Hematopoietic and Lymphatic System Neoplasm 1Hematologic Neoplasms 1Emotional Regulation 1Breast Neoplasms 1Anxiety Disorders 1Advanced Cancer 1

Interventions

Interviews as Topic 12Specimen Handling 11Practice Guidelines as Topic 8Standard of Care 7Educational Status 6Patient Navigation 4Methods 4Early Intervention, Educational 4Acupressure 3Telemedicine 2Health Promotion 2Behavior Therapy 2Aromatherapy 2theanine 1ruxolitinib 1merphos 1lavender oil 1jojoba wax 1axatilimab 1X-Rays 1Triptorelin Pamoate 1Tacrolimus 1Surveys and Questionnaires 1Stem Cell Transplantation 1Spiritual Therapies 1Spinal Puncture 1Restraint, Physical 1Resistance Training 1Psychotherapy 1Psilocybin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematopoietic and Lymphatic System Neoplasm × Psychotherapy × 1 year × Clear all
NCT06827054 2026-03-24

Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids

Roswell Park Cancer Institute

Phase 2 Not yet recruiting
20 enrolled
Other solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡